Annalisa Ruggeri

European Organisation for Rare Diseases — France

Medicine · Health Sciences

64h-index16.0kcitations515works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(327), Acute Myeloid Leukemia Research(136), Acute Lymphoblastic Leukemia research(116), Immune Cell Function and Interaction(71), Polyomavirus and related diseases(64)

Publications514 total

Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition
Bone Marrow Transplantation·2025
Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class
Bone Marrow Transplantation·2025· 1 cited
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Bone Marrow Transplantation·2025
Impact of busulfan- versus treosulfan-based conditioning on the incidence of sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation: a dual-center real-world study
Bone Marrow Transplantation·2025· 1 cited
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT
Bone Marrow Transplantation·2025
Survey on fertility management and outcomes after cellular therapies, on behalf of the EBMT cellular therapy and immunobiology working party
Blood·2025Open Access
Current practices, organizational structures, technologies and challenges in developing atmps: A survey by dare-NL, nxtgen hightech, T2EVOLVE and ctiwp of EBMT - a gocart-coalition initiative
Blood·2025Open Access
Anti-CD19 chimeric antigen receptor T-cells therapy (CAR-T) is effective in secondary cns lymphoma (SCNSL) refractory to high-dose methotrexate (HDMTX)-based chemotherapy
Blood·2025Open Access
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
The Lancet Oncology·2025· 3 cited
Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee
HemaSphere·2025Open Access
Allogeneic haematopoietic cell transplant in cutaneous T‐cell lymphomas: Recommendations from the <scp>EBMT PH</scp> &amp;G Committee
Journal of the European Academy of Dermatology and Venereology·2025· 1 citedOpen Access
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&amp;G Committee
Bone Marrow Transplantation·2025Open Access
Single unrelated umbilical cord blood versus unmanipulated haploidentical HCT using PTCy in pediatric AML: a retrospective study on behalf of the EBMT PDWP and CTIWP
Bone Marrow Transplantation·2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations
Bone Marrow Transplantation·2025· 3 citedOpen Access
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era
Haematologica·2025· 1 citedOpen Access
1047P Contemporary outcomes of salvage high-dose chemotherapy (HDCT) in advanced germ cell tumors (GCTs): An analysis of the European Society for blood and marrow transplantation (EBMT) registry
Annals of Oncology·2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
Bone Marrow Transplantation·2025· 3 citedOpen Access
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome
Frontiers in Immunology·2025· 2 citedOpen Access
Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress
Bone Marrow Transplantation·2025· 1 cited
Impact of the addition of antithymocyte globulin to post‐transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post‐transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation
British Journal of Haematology·2025· 1 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Fabio Ciceri(25), Mohamad Mohty(19), Myriam Labopin(18), Éliane Gluckman(16), Arnon Nagler(16), Didier Blaise(11), Mary Eapen(10), Vanderson Rocha(10), Patrizia Rovere‐Querini(9), Moreno Tresoldi(9), Giovanni Landoni(9), Alberto Zangrillo(9), Lorenzo Dagna(9), Joanne Kurtzberg(8), Vanderson Rocha(7), Éolia Brissot(7), Florent Malard(7), Paolo Scarpellini(6), Guillermo Sanz(6), William Arcese(6)